‘Viagra for women’ will get third chance at FDA approval
WASHINGTON — The makers of a twice-rejected pill intended to boost libido in women will try once again this week to persuade regulators that the drug warrants approval as the first prescription treatment for low sexual desire in women. But a new review released by the Food and Drug Administration shows government scientists still have concerns about whether the drug's benefits outweigh its risks. The FDA review highlights several safety issues with flibanserin, including low blood pressure and fainting spells. Those problems increased when patients combined the drug with alcohol.
Post to Tumblr